Oss, The Netherlands & Dublin, Ireland, 16 March 2018 – H. Lundbeck A/S (Lundbeck) and Seroba’s Investee C... Read more

Seroba’s investee company, Prexton Therapeutics (Prexton), a biopharma company developing novel therapeutic compounds for the treatme... Read more

 

Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic.... Read more

TOP